Valeant Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VALEANT PHARMS, and when can generic versions of VALEANT PHARMS drugs launch?
VALEANT PHARMS has twenty-two approved drugs.
There are six US patents protecting VALEANT PHARMS drugs.
There are forty-four patent family members on VALEANT PHARMS drugs in twelve countries and eighteen supplementary protection certificates in twelve countries.
Summary for Valeant Pharms
International Patents: | 44 |
US Patents: | 6 |
Tradenames: | 17 |
Ingredients: | 15 |
NDAs: | 22 |
Drugs and US Patents for Valeant Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant Pharms North | NIFEDIPINE | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 075289-001 | Sep 27, 2000 | AB2 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Valeant Pharms | PENTOXIFYLLINE | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 075028-001 | Jul 20, 1998 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Valeant Pharms North | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 090071-002 | Apr 15, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Valeant Pharms North | CARAC | fluorouracil | CREAM;TOPICAL | 020985-001 | Oct 27, 2000 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Valeant Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Valeant Pharms North | CARAC | fluorouracil | CREAM;TOPICAL | 020985-001 | Oct 27, 2000 | 4,690,825 | ⤷ Try a Trial |
Valeant Pharms | ULTRAM ER | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021692-003 | Sep 8, 2005 | 6,254,887 | ⤷ Try a Trial |
Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 021108-001 | Aug 31, 2000 | 4,603,146 | ⤷ Try a Trial |
Valeant Pharms | ULTRAM ER | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021692-002 | Sep 8, 2005 | 6,254,887 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for VALEANT PHARMS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Extended-release Tablets | 100 mg | ➤ Subscribe | 2007-01-08 |
➤ Subscribe | Extended-release Tablets | 300 mg | ➤ Subscribe | 2007-09-25 |
➤ Subscribe | Cream | 0.5% | ➤ Subscribe | 2011-07-29 |
➤ Subscribe | Extended-release Tablets | 200 mg | ➤ Subscribe | 2007-03-28 |
➤ Subscribe | Tablets | 1.1 g | ➤ Subscribe | 2013-11-05 |
International Patents for Valeant Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2015108021 | ⤷ Try a Trial |
Australia | 2007322362 | ⤷ Try a Trial |
Mexico | 2008002283 | ⤷ Try a Trial |
European Patent Office | 2563117 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Valeant Pharms Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1304992 | C300617 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322 |
1304992 | 2013/044 | Ireland | ⤷ Try a Trial | PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322 |
0617614 | 2001/009 | Ireland | ⤷ Try a Trial | PRODUCT NAME: PANRETIN-ALITRETINOIN |
0566709 | C300152 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: TRAMADOLI HYDROCHLORIDUM EN PARACETAMOLUM; NAT. REGISTRATION NO/DATE: RVG 28113 20030115; FIRST REGISTRATION: 359 228-3 2002050405 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.